Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zenas BioPharma, Inc.ZBIO · Entity 275 | See Remarks | June 10, 2025 | June 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zenas BioPharma, Inc.
Report date June 10, 2025 · Filed June 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.94 · Expires 2035-06-10 | Direct | 100,000 |
Reported balance
After 2025-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-10 · Grant · Acquired 100,000 · Balance 100,000 F1: The option vests as to 25% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TESARO, Inc.
Report date January 22, 2019 · Filed January 22, 2019
Section 16 reporting ended · disclosed 2019-01-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 1
1 source rowRow 1 · 2019-01-22 · Other · Disposed 29,378 · Balance 0 F1: Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-01-22 · Disposition to issuer · Disposed 1,250 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-01-22 · Disposition to issuer · Disposed 8,750 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-01-22 · Disposition to issuer · Disposed 4,447 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-01-22 · Disposition to issuer · Disposed 18,182 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.69 · Expires 2025-09-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-01-22 · Disposition to issuer · Disposed 14,063 · Balance 0 F4: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.39 · Expires 2026-03-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-01-22 · Disposition to issuer · Disposed 10,938 · Balance 0 F4: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $178.95 · Expires 2027-03-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-01-22 · Disposition to issuer · Disposed 10,782 · Balance 0 F4: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.84 · Expires 2028-03-01 | Direct | 0 |
Reported balance
After 2019-01-22 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-01-22 · Disposition to issuer · Disposed 25,963 · Balance 0 F4: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. |
Filing footnotes · ownership attribution and instrument terms
F1: Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement").
F2: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock.
F3: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share.
F4: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd]
F5: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2025 Filed Jun 12, 2025 16:37 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $11.94 | $0.00 |
DisclosureSEC source: 0001104659-25-058940 · tm2517684-9_4seq1.xml · derivative · entry 1 Oliveira Orlando · CIK 0001699305 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-06-10 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 16:30 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantStock Option (Right to Buy) · Derivative | 7,775 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001104659-24-129776 · tm2431489-1_4seq1.xml · derivative · entry 1 Oliveira Orlando · CIK 0001699305 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,775 Underlying: Common Stock · 7,775 shares Expires 2034-12-15 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on July 1, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 20:52 UTC | Zenas BioPharma, Inc. ZBIO · Entity 275 | GrantStock Option (Right to Buy) · Derivative | 410,000 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-24-100328 · tm2424157-8_4seq1.xml · derivative · entry 1 Oliveira Orlando · CIK 0001699305 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,000 Underlying: Common Stock · 410,000 shares Expires 2034-09-11 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on July 1, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 25,963 | Not disclosed Strike: $55.84 | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 9 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,963 shares Expires 2028-03-01 F4 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 10,782 | Not disclosed Strike: $178.95 | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 8 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,782 shares Expires 2027-03-01 F4 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 10,938 | Not disclosed Strike: $43.39 | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 7 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,938 shares Expires 2026-03-01 F4 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 14,063 | Not disclosed Strike: $51.69 | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 6 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,063 shares Expires 2025-09-01 F4 · price: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · price: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, each option that was outstanding and unvested immediately prior to the Effective Time vested in full at the Effective Time. [Cont'd] F5 · derivative.exercise_date: [Continuation] Each option that was outstanding immediately prior to the Effective Time that had an exercise price per share less than $75.00 was cancelled in exchange for the right of the holder to receive (without interest) an amount in cash (less applicable withholding of taxes required by applicable law) equal to the product of (i) the total number of shares of TESARO common stock subject to the unexercised portion of such option immediately prior to the Effective Time (determined after giving effect to the accelerated vesting described in the previous sentence) multiplied by (ii) the excess, if any, of $75.00 over the applicable exercise price per share under such option. Each option that was outstanding immediately prior to the Effective Time with an exercise price per share that is greater than or equal to $75.00 was cancelled at the Effective Time, and the holder of such option is not entitled to any payment in exchange for the cancellation of the option. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 18,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 5 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,182 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 4,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 4 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,447 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 3 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | Disposition to issuerRestricted Stock Units · Derivative | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · derivative · entry 2 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · price: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.exercise_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. F3 · derivative.expiration_date: These restricted stock units were cancelled pursuant to the Merger Agreement at the effective time of the Merger (the "Effective Time") in exchange for a cash payment of $75.00 per share. Read SEC document |
| January 22, 2019 Filed Jan 22, 2019 09:57 UTC | TESARO, Inc. TSRO · Entity 160894 | OtherCommon Stock | 29,378 | $75.00 | $2,203,350.00 |
DisclosureSEC source: 0001123292-19-000171 · edgar.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Tendered in connection with the tender offer made by Adriatic Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of GlaxoSmithKline plc, a public company organized under the laws of England and Wales ("Parent"), to purchase all of the issued and outstanding shares of TESARO, Inc., a Delaware corporation ("TESARO"), for $75.00 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of December 3, 2018 by and among TESARO, Purchaser, and Parent (the "Merger Agreement"). Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 39,062 | $0.00 Strike: $51.69 | $0.00 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · derivative · entry 7 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,063 Underlying: Common Stock · 39,062 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The remaining portion of the option is unvested and vests in equal installments on the first of each month through September 1, 2019. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,229 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · derivative · entry 6 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Stock · 18,229 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The remaining portion of the option is unvested and vests in equal installments on the first of each month through March 1, 2020. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,991 | $0.00 Strike: $55.84 | $0.00 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · derivative · entry 5 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,963 Underlying: Common Stock · 5,991 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The remaining portion of the option is unvested and vests in equal installments on the first of each month through March 1, 2022. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Tax withholdingCommon Stock | 44,158 | $73.10 | $3,227,949.80 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · nonDerivative · entry 4 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,378 Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 39,062 | $51.69 | $2,019,114.78 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · nonDerivative · entry 3 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 18,229 | $43.39 | $790,956.31 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · nonDerivative · entry 2 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 19:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 5,991 | $55.84 | $334,537.44 |
DisclosureSEC source: 0001104659-18-074522 · a4.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 17:04 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 72 | $32.44 | $2,335.68 |
DisclosureSEC source: 0001104659-18-055379 · a4.xml · nonDerivative · entry 2 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,254 F1 · kind: This sale was effected in accordance with the terms of the underlying restricted stock unit award agreement and a 10b5-1 Trading Plan entered into by the Reporting Person and was made in order to pay the tax liability arising from the vesting of the restricted stock units. Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 17:04 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-055379 · a4.xml · derivative · entry 3 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · derivative.exercise_date: The restricted stock units were granted on September 1, 2015 and vest in four equal annual installments beginning September 1, 2016. F3 · derivative.expiration_date: The restricted stock units were granted on September 1, 2015 and vest in four equal annual installments beginning September 1, 2016. Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 17:04 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-055379 · a4.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 17:14 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 3,000 | $69.88 | $209,640.00 |
DisclosureSEC source: 0001104659-18-016393 · a4.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,076 F1 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $69.865 to $69.886, inclusive. The reporting person undertakes to provide to TESARO, any security holder of TESARO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 337 | $54.86 | $18,487.82 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · nonDerivative · entry 3 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,076 F1 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. F2 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $54.80 to $54.87, inclusive. The reporting person undertakes to provide to TESARO, any security holder of TESARO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantEmployee Stock Option (right to buy) · Derivative | 31,954 | $0.00 Strike: $55.84 | $0.00 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · derivative · entry 7 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,954 Underlying: Common Stock · 31,954 shares Expires 2028-03-01 F7 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 1, 2018. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantRestricted Stock Units · Derivative | 18,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · derivative · entry 6 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,182 Underlying: Common Stock · 18,182 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F6 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on March 1, 2019. F6 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on March 1, 2019. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 1,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · derivative · entry 5 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,447 Underlying: Common Stock · 1,483 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F5 · derivative.exercise_date: The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021. F5 · derivative.expiration_date: The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · derivative · entry 4 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 4,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · derivative.exercise_date: The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020. F4 · derivative.expiration_date: The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 1,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · nonDerivative · entry 2 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 17:25 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-014883 · a4.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 21:13 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 71 | $132.66 | $9,418.86 |
DisclosureSEC source: 0001104659-17-055905 · a4.xml · nonDerivative · entry 2 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,555 F1 · kind: This sale was effected in accordance with the terms of the underlying restricted stock unit award agreement and was made in order to pay the tax liability arising from the vesting of the restricted stock units. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:13 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-055905 · a4.xml · derivative · entry 3 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · derivative.exercise_date: The restricted stock units were granted on September 1, 2015 and vest in four equal annual installments beginning September 1, 2016. F3 · derivative.expiration_date: The restricted stock units were granted on September 1, 2015 and vest in four equal annual installments beginning September 1, 2016. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:13 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-055905 · a4.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | SaleCommon Stock | 249 | $177.61 | $44,224.89 |
DisclosureSEC source: 0001104659-17-014114 · a4.xml · nonDerivative · entry 2 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,376 F1 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantEmployee Stock Option (right to buy) · Derivative | 10,782 | $0.00 Strike: $178.95 | $0.00 |
DisclosureSEC source: 0001104659-17-014114 · a4.xml · derivative · entry 5 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,782 Underlying: Common Stock · 10,782 shares Expires 2027-03-01 F5 · derivative.exercise_date: The option vests in 48 equal monthly installments beginning on April 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | GrantRestricted Stock Units · Derivative | 5,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014114 · a4.xml · derivative · entry 4 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,930 Underlying: Common Stock · 5,930 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2018. F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2018. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionRestricted Stock Units · Derivative | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014114 · a4.xml · derivative · entry 3 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 4,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TESARO common stock. F3 · derivative.exercise_date: The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017. F3 · derivative.expiration_date: The restricted stock units were granted on March 1, 2016 and vest in four equal annual installments beginning on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:18 UTC | TESARO, Inc. TSRO · Entity 160894 | Exercise / conversionCommon Stock | 4,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-014114 · a4.xml · nonDerivative · entry 1 Oliveira Orlando · CIK 0001699305 · SVP & GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.